Menopause Treatment Market Synopsis:
Menopause Treatment Market Size Was Valued at USD 15.33 Billion in 2023, and is Projected to Reach USD 25.68 Billion by 2032, Growing at a CAGR of 5.9% From 2024-2032.
The Menopause treatment is a novel market I have defined as products and therapies for menopausal women, which are specifically aimed for women who have passed their reproductive age. Such therapies consist of Hormone Replacement Therapy (HRT), non-estrogen therapy, phytoestrogen, and others; dietary supplements; and lifestyle change. The market targets cure some of the symptoms like hot flare, mood swings, sleeplessness and vaginal dryness that pose a quality-of-life threat among women going through menopause. With increased knowledge of menopause and its remedies, the market is extending to offer new therapeutic solutions an extensive range of demographic.
Treatment for menopausal has experienced a growth in the recent past due to a high number of women who are getting to the stage and awareness of women’s health. Since women are living longer and more go through menopause, which is said to occur between 45 and 55, the need for suitable therapies is increasing. Recent development in medical research and product development have ensured that women got a variety of choices where they have to seek treatment. In addition, shifting cultures regarding the subject matter of menopause are also limiting stigmatization of the condition to ensure women seek treatment.
In addition, evidence of the increase of postmenopausal disorders such as osteoporosis and cardiovascular diseases has led to the need for an elaborate treatment plan which considers both medical and lifestyle changes as well as preventive measures. The market is also changing with products that contain natural plant derived substances as people are now embracing natural products for treatments. Technological improvements in telehealth solutions and digital health, patient kits, and related applications also drive the increase of market access to women, therefore contributing to market growth. In summary, the menopause treatment market is expected to deepen its growth in the future due to the constant changes that healthcare facilities and pharmaceutical firms make to address postmenopausal female concerns.
Menopause Treatment Market Trend Analysis:
Increased Adoption of Telehealth Solutions
- One of the more significant trends present in the marketing of menopause treatment is the use of telehealth solutions. This benefit was evident due to the COVID 19 outbreak, which forced many women to seek the services of a health care provider without physical contact. Such a trend has proved helpful for women going through the menopause period and who may feel uneasy to express themselves in clinical settings. Telehealth services provide more improved access to specialized care, thus enshrine a personal health plan, and constant care that is vital when managing the symptoms experienced during menopause.
- Also, telehealth solutions are now developing knowledge sharing databases and communities that support a woman’s self-managed menopause process. Webinars, virtual meetings and online support groups are getting more prevalent to ensure women can come together, discuss what they are going through and how they can handle it. Not only does this trend improve treatment effect but also creates the atmosphere of knowing and supporting women in similar situations. Telehealth continues to remain an important tool in the delivery of care as the market for menopause treatment expands; making care more accessible.
Expansion of Natural and Holistic Treatments
- The gap which is worth exploiting as the market for treatment of menopause progresses is natural and even holistic approach. As women begin to learn of the risks associated with traditional hormone replacement therapy, they are focusing on the effective solutions that can be obtained through natural and organic products. It creates the possibility of designing a new category of solutions that would help menopausal women manage their symptoms without having to consider using traditional drugs with their dangerous effects.
Menopause Treatment Market Segment Analysis:
Menopause Treatment Market is Segmented based on Treatment, Route of Administration Form, Indication, End User, and Region
By Treatment, Hormone Therapy segment is expected to dominate the market during the forecast period
- Historically endowed segment likely to dominate the Menopause treatment market over through the entirely of the forecast period is the hormonal therapy segment due to its capability to reduce the discomfort associated with hot flushes, night sweats and mood swings associated with menopause medical conditions. This has been so as they looked at hormone replacement therapy (HRT) as being crucial in easing such pains besides improving the flexibility of many women. Due to the change in the style of prescribing from healthcare professionals in terms of hormone replacement therapy, formulation and delivery systems are enhancing medication compliance and satisfaction among patients. Also, new information on the potential benefits of HRT, and the data on the safe application of this therapy unequivocally places it in a position above other therapies in terms of the market for managing the menopause.
By Route Of Administration, Oral segment expected to held the largest share
- Of the two segments it is identified that oral segment is expected to dominate the market particularly due to the absorbability and simplicity associated with them. Taking menopause therapies orally makes it easy for women to consume these drugs and therapies without the complex method of administration like injection among others. Many patients preferred this rout of administration since it is painless compared to injections or even topical application. Furthermore, new developments on oral forms, which include increased bioavailability and minimized side effects, have greatly enhanced the use of oral treatments. Since health professionals are still campaigning for affordable and easy to administer treatment personnel, the oral segment is well positioned to grow steadily in the menopause treatment market.
Menopause Treatment Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
- According to analysts, in 2023, North America will remain the largest consumer of products and services in the global menopause treatment market with 40% stake. This high percentage can be attributed to such factors as increased knowledge of MENOPAUSE health complications; easy access to superior medical care and increasing focus on women health. This has placed the region in a better strategic position since patients will be able to access a variety of treatment methods including hormonal therapy and lifestyle modification programs. Furthermore, the market has benefitted from the recent focus on menopause as a crucial phase in a woman’s health; thereby more patients are accessing treatment to meet their needs.
Active Key Players in the Menopause Treatment Market:
- AbbVie Inc. (USA)
- Allergan (Ireland)
- Amgen Inc. (USA)
- Bayer AG (Germany)
- Endo Pharmaceuticals (USA)
- Ferring Pharmaceuticals (Switzerland)
- GSK (GlaxoSmithKline) (UK)
- HRA Pharma (France)
- Johnson & Johnson (USA)
- Merck & Co., Inc. (USA)
- Mylan N.V. (USA)
- Novo Nordisk (Denmark)
- Pfizer Inc. (USA)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Thermo Fisher Scientific (USA)
- Other Active Players
|
Menopause Treatment Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 15.33 Billion |
|
Forecast Period 2024-32 CAGR: |
5.9 % |
Market Size in 2032: |
USD 25.68 Billion |
|
Segments Covered: |
By Treatmnet |
|
|
|
By Route Of Adminstration |
|
||
|
By Form |
|
||
|
By Indication |
|
||
|
End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Menopause Treatment Market by Treatment
4.1 Menopause Treatment Market Snapshot and Growth Engine
4.2 Menopause Treatment Market Overview
4.3 Hormone Therapy
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Hormone Therapy: Geographic Segmentation Analysis
4.4 Non-hormonal Therapy
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Non-hormonal Therapy: Geographic Segmentation Analysis
4.5 Others
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Others: Geographic Segmentation Analysis
Chapter 5: Menopause Treatment Market by Route Of Administration
5.1 Menopause Treatment Market Snapshot and Growth Engine
5.2 Menopause Treatment Market Overview
5.3 Oral
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Oral: Geographic Segmentation Analysis
5.4 Topical
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Topical: Geographic Segmentation Analysis
5.5 Parental
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Parental: Geographic Segmentation Analysis
5.6 Vaginal
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Vaginal: Geographic Segmentation Analysis
5.7 Others
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Others: Geographic Segmentation Analysis
Chapter 6: Menopause Treatment Market by Form
6.1 Menopause Treatment Market Snapshot and Growth Engine
6.2 Menopause Treatment Market Overview
6.3 Tablets
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Tablets: Geographic Segmentation Analysis
6.4 Cream
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Cream: Geographic Segmentation Analysis
6.5 Patches
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Patches: Geographic Segmentation Analysis
6.6 Pessaries
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Pessaries: Geographic Segmentation Analysis
6.7 Injections
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Injections: Geographic Segmentation Analysis
6.8 Others
6.8.1 Introduction and Market Overview
6.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.8.3 Key Market Trends, Growth Factors and Opportunities
6.8.4 Others: Geographic Segmentation Analysis
Chapter 7: Menopause Treatment Market by Indication
7.1 Menopause Treatment Market Snapshot and Growth Engine
7.2 Menopause Treatment Market Overview
7.3 Perimenopause
7.3.1 Introduction and Market Overview
7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.3.3 Key Market Trends, Growth Factors and Opportunities
7.3.4 Perimenopause: Geographic Segmentation Analysis
7.4 Menopause
7.4.1 Introduction and Market Overview
7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.4.3 Key Market Trends, Growth Factors and Opportunities
7.4.4 Menopause: Geographic Segmentation Analysis
Chapter 8: Menopause Treatment Market by End Users
8.1 Menopause Treatment Market Snapshot and Growth Engine
8.2 Menopause Treatment Market Overview
8.3 Hospitals
8.3.1 Introduction and Market Overview
8.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
8.3.3 Key Market Trends, Growth Factors and Opportunities
8.3.4 Hospitals: Geographic Segmentation Analysis
8.4 Pharmacies
8.4.1 Introduction and Market Overview
8.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
8.4.3 Key Market Trends, Growth Factors and Opportunities
8.4.4 Pharmacies: Geographic Segmentation Analysis
8.5 Online Pharmacies
8.5.1 Introduction and Market Overview
8.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
8.5.3 Key Market Trends, Growth Factors and Opportunities
8.5.4 Online Pharmacies: Geographic Segmentation Analysis
8.6 Specialty Store
8.6.1 Introduction and Market Overview
8.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
8.6.3 Key Market Trends, Growth Factors and Opportunities
8.6.4 Specialty Store: Geographic Segmentation Analysis
Chapter 9: Company Profiles and Competitive Analysis
9.1 Competitive Landscape
9.1.1 Competitive Benchmarking
9.1.2 Menopause Treatment Market Share by Manufacturer (2023)
9.1.3 Industry BCG Matrix
9.1.4 Heat Map Analysis
9.1.5 Mergers and Acquisitions
9.2 PFIZER INC. (USA)
9.2.1 Company Overview
9.2.2 Key Executives
9.2.3 Company Snapshot
9.2.4 Role of the Company in the Market
9.2.5 Sustainability and Social Responsibility
9.2.6 Operating Business Segments
9.2.7 Product Portfolio
9.2.8 Business Performance
9.2.9 Key Strategic Moves and Recent Developments
9.2.10 SWOT Analysis
9.3 BAYER AG (GERMANY)
9.4 JOHNSON & JOHNSON (USA)
9.5 NOVO NORDISK (DENMARK)
9.6 OTHER ACTIVE PLAYERS
Chapter 10: Global Menopause Treatment Market By Region
10.1 Overview
10.2. North America Menopause Treatment Market
10.2.1 Key Market Trends, Growth Factors and Opportunities
10.2.2 Top Key Companies
10.2.3 Historic and Forecasted Market Size by Segments
10.2.4 Historic and Forecasted Market Size By Treatment
10.2.4.1 Hormone Therapy
10.2.4.2 Non-hormonal Therapy
10.2.4.3 Others
10.2.5 Historic and Forecasted Market Size By Route Of Administration
10.2.5.1 Oral
10.2.5.2 Topical
10.2.5.3 Parental
10.2.5.4 Vaginal
10.2.5.5 Others
10.2.6 Historic and Forecasted Market Size By Form
10.2.6.1 Tablets
10.2.6.2 Cream
10.2.6.3 Patches
10.2.6.4 Pessaries
10.2.6.5 Injections
10.2.6.6 Others
10.2.7 Historic and Forecasted Market Size By Indication
10.2.7.1 Perimenopause
10.2.7.2 Menopause
10.2.8 Historic and Forecasted Market Size By End Users
10.2.8.1 Hospitals
10.2.8.2 Pharmacies
10.2.8.3 Online Pharmacies
10.2.8.4 Specialty Store
10.2.9 Historic and Forecast Market Size by Country
10.2.9.1 US
10.2.9.2 Canada
10.2.9.3 Mexico
10.3. Eastern Europe Menopause Treatment Market
10.3.1 Key Market Trends, Growth Factors and Opportunities
10.3.2 Top Key Companies
10.3.3 Historic and Forecasted Market Size by Segments
10.3.4 Historic and Forecasted Market Size By Treatment
10.3.4.1 Hormone Therapy
10.3.4.2 Non-hormonal Therapy
10.3.4.3 Others
10.3.5 Historic and Forecasted Market Size By Route Of Administration
10.3.5.1 Oral
10.3.5.2 Topical
10.3.5.3 Parental
10.3.5.4 Vaginal
10.3.5.5 Others
10.3.6 Historic and Forecasted Market Size By Form
10.3.6.1 Tablets
10.3.6.2 Cream
10.3.6.3 Patches
10.3.6.4 Pessaries
10.3.6.5 Injections
10.3.6.6 Others
10.3.7 Historic and Forecasted Market Size By Indication
10.3.7.1 Perimenopause
10.3.7.2 Menopause
10.3.8 Historic and Forecasted Market Size By End Users
10.3.8.1 Hospitals
10.3.8.2 Pharmacies
10.3.8.3 Online Pharmacies
10.3.8.4 Specialty Store
10.3.9 Historic and Forecast Market Size by Country
10.3.9.1 Russia
10.3.9.2 Bulgaria
10.3.9.3 The Czech Republic
10.3.9.4 Hungary
10.3.9.5 Poland
10.3.9.6 Romania
10.3.9.7 Rest of Eastern Europe
10.4. Western Europe Menopause Treatment Market
10.4.1 Key Market Trends, Growth Factors and Opportunities
10.4.2 Top Key Companies
10.4.3 Historic and Forecasted Market Size by Segments
10.4.4 Historic and Forecasted Market Size By Treatment
10.4.4.1 Hormone Therapy
10.4.4.2 Non-hormonal Therapy
10.4.4.3 Others
10.4.5 Historic and Forecasted Market Size By Route Of Administration
10.4.5.1 Oral
10.4.5.2 Topical
10.4.5.3 Parental
10.4.5.4 Vaginal
10.4.5.5 Others
10.4.6 Historic and Forecasted Market Size By Form
10.4.6.1 Tablets
10.4.6.2 Cream
10.4.6.3 Patches
10.4.6.4 Pessaries
10.4.6.5 Injections
10.4.6.6 Others
10.4.7 Historic and Forecasted Market Size By Indication
10.4.7.1 Perimenopause
10.4.7.2 Menopause
10.4.8 Historic and Forecasted Market Size By End Users
10.4.8.1 Hospitals
10.4.8.2 Pharmacies
10.4.8.3 Online Pharmacies
10.4.8.4 Specialty Store
10.4.9 Historic and Forecast Market Size by Country
10.4.9.1 Germany
10.4.9.2 UK
10.4.9.3 France
10.4.9.4 The Netherlands
10.4.9.5 Italy
10.4.9.6 Spain
10.4.9.7 Rest of Western Europe
10.5. Asia Pacific Menopause Treatment Market
10.5.1 Key Market Trends, Growth Factors and Opportunities
10.5.2 Top Key Companies
10.5.3 Historic and Forecasted Market Size by Segments
10.5.4 Historic and Forecasted Market Size By Treatment
10.5.4.1 Hormone Therapy
10.5.4.2 Non-hormonal Therapy
10.5.4.3 Others
10.5.5 Historic and Forecasted Market Size By Route Of Administration
10.5.5.1 Oral
10.5.5.2 Topical
10.5.5.3 Parental
10.5.5.4 Vaginal
10.5.5.5 Others
10.5.6 Historic and Forecasted Market Size By Form
10.5.6.1 Tablets
10.5.6.2 Cream
10.5.6.3 Patches
10.5.6.4 Pessaries
10.5.6.5 Injections
10.5.6.6 Others
10.5.7 Historic and Forecasted Market Size By Indication
10.5.7.1 Perimenopause
10.5.7.2 Menopause
10.5.8 Historic and Forecasted Market Size By End Users
10.5.8.1 Hospitals
10.5.8.2 Pharmacies
10.5.8.3 Online Pharmacies
10.5.8.4 Specialty Store
10.5.9 Historic and Forecast Market Size by Country
10.5.9.1 China
10.5.9.2 India
10.5.9.3 Japan
10.5.9.4 South Korea
10.5.9.5 Malaysia
10.5.9.6 Thailand
10.5.9.7 Vietnam
10.5.9.8 The Philippines
10.5.9.9 Australia
10.5.9.10 New Zealand
10.5.9.11 Rest of APAC
10.6. Middle East & Africa Menopause Treatment Market
10.6.1 Key Market Trends, Growth Factors and Opportunities
10.6.2 Top Key Companies
10.6.3 Historic and Forecasted Market Size by Segments
10.6.4 Historic and Forecasted Market Size By Treatment
10.6.4.1 Hormone Therapy
10.6.4.2 Non-hormonal Therapy
10.6.4.3 Others
10.6.5 Historic and Forecasted Market Size By Route Of Administration
10.6.5.1 Oral
10.6.5.2 Topical
10.6.5.3 Parental
10.6.5.4 Vaginal
10.6.5.5 Others
10.6.6 Historic and Forecasted Market Size By Form
10.6.6.1 Tablets
10.6.6.2 Cream
10.6.6.3 Patches
10.6.6.4 Pessaries
10.6.6.5 Injections
10.6.6.6 Others
10.6.7 Historic and Forecasted Market Size By Indication
10.6.7.1 Perimenopause
10.6.7.2 Menopause
10.6.8 Historic and Forecasted Market Size By End Users
10.6.8.1 Hospitals
10.6.8.2 Pharmacies
10.6.8.3 Online Pharmacies
10.6.8.4 Specialty Store
10.6.9 Historic and Forecast Market Size by Country
10.6.9.1 Turkiye
10.6.9.2 Bahrain
10.6.9.3 Kuwait
10.6.9.4 Saudi Arabia
10.6.9.5 Qatar
10.6.9.6 UAE
10.6.9.7 Israel
10.6.9.8 South Africa
10.7. South America Menopause Treatment Market
10.7.1 Key Market Trends, Growth Factors and Opportunities
10.7.2 Top Key Companies
10.7.3 Historic and Forecasted Market Size by Segments
10.7.4 Historic and Forecasted Market Size By Treatment
10.7.4.1 Hormone Therapy
10.7.4.2 Non-hormonal Therapy
10.7.4.3 Others
10.7.5 Historic and Forecasted Market Size By Route Of Administration
10.7.5.1 Oral
10.7.5.2 Topical
10.7.5.3 Parental
10.7.5.4 Vaginal
10.7.5.5 Others
10.7.6 Historic and Forecasted Market Size By Form
10.7.6.1 Tablets
10.7.6.2 Cream
10.7.6.3 Patches
10.7.6.4 Pessaries
10.7.6.5 Injections
10.7.6.6 Others
10.7.7 Historic and Forecasted Market Size By Indication
10.7.7.1 Perimenopause
10.7.7.2 Menopause
10.7.8 Historic and Forecasted Market Size By End Users
10.7.8.1 Hospitals
10.7.8.2 Pharmacies
10.7.8.3 Online Pharmacies
10.7.8.4 Specialty Store
10.7.9 Historic and Forecast Market Size by Country
10.7.9.1 Brazil
10.7.9.2 Argentina
10.7.9.3 Rest of SA
Chapter 11 Analyst Viewpoint and Conclusion
11.1 Recommendations and Concluding Analysis
11.2 Potential Market Strategies
Chapter 12 Research Methodology
12.1 Research Process
12.2 Primary Research
12.3 Secondary Research
|
Menopause Treatment Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 15.33 Billion |
|
Forecast Period 2024-32 CAGR: |
5.9 % |
Market Size in 2032: |
USD 25.68 Billion |
|
Segments Covered: |
By Treatmnet |
|
|
|
By Route Of Adminstration |
|
||
|
By Form |
|
||
|
By Indication |
|
||
|
End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
